Lee Ainslie Collegium Pharmaceutical, Inc Transaction History

Maverick Capital LTD

$5.07 Billion
Q2 2024

A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Maverick Capital LTD holds 39,596 shares of COLL stock, worth $1.37 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

39,596

Previous 8,873 346.25%

Holding current value

$1.37 Million

Previous $344,000 270.35%

% of portfolio

0.03%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$31.36 - $39.99 $963,473 - $1.23 Million	30,723 Added 346.25%	39,596 $1.27 Million
Q1 2024 May 15, 2024	BUY	$31.23 - $40.91 $277,103 - $362,994	8,873 New	8,873 $344,000
Q2 2023 Aug 14, 2023	SELL	$21.06 - $24.0 $18,848 - $21,480	-895 Reduced 7.92%	10,401 $223,000
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $12,765 - $16,583	555 Added 5.17%	11,296 $270,000
Q4 2022 Feb 14, 2023	SELL	$16.14 - $23.55 $64,414 - $93,988	-3,991 Reduced 27.09%	10,741 $249,000
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $227,756 - $296,113	14,732 New	14,732 $236,000
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $599,080 - $856,937	-33,751 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$21.74 - $25.28 $733,746 - $853,225	33,751 New	33,751 $798,000
Q1 2021 May 17, 2021	SELL	$19.25 - $26.1 $133,325 - $180,768	-6,926 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$17.83 - $22.29 $123,490 - $154,380	6,926 New	6,926 $139,000
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $4.2 Million - $6.55 Million	-395,080 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$13.58 - $18.72 $5.37 Million - $7.4 Million	395,080 New	395,080 $5.98 Million
Q4 2018 Feb 14, 2019	SELL	$14.78 - $19.68 $6.24 Million - $8.3 Million	-421,993 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$14.16 - $24.3 $36,773 - $63,107	-2,597 Reduced 0.61%	421,993 $6.22 Million
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $9.25 Million - $12 Million	424,590 New	424,590 $10.1 Million

Others Institutions Holding COLL

# of Institutions

239

Shares Held

39.7M

Call Options Held

84.2K

Put Options Held

18.6K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.18B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track Lee Ainslie's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Account